DrugPatentWatch Database Preview

Chartwell Molecular Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?

CHARTWELL MOLECULAR has eight approved drugs.

Summary for Chartwell Molecular

US Patents:	0
Tradenames:	8
Ingredients:	8
NDAs:	8

Drugs and US Patents for Chartwell Molecular

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecular	CARVEDILOL	carvedilol	TABLET;ORAL	077474-003	Sep 5, 2007	AB	RX	No	No
Chartwell Molecular	CARVEDILOL	carvedilol	TABLET;ORAL	077474-002	Sep 5, 2007	AB	RX	No	No
Chartwell Molecular	FOLIC ACID	folic acid	TABLET;ORAL	090035-001	Jun 9, 2009	AA	RX	No	No
Chartwell Molecular	CARVEDILOL	carvedilol	TABLET;ORAL	077474-001	Sep 5, 2007	AB	RX	No	No
Chartwell Molecular	RAMIPRIL	ramipril	CAPSULE;ORAL	078745-002	Jun 18, 2008	AB	RX	No	No
Chartwell Molecular	RISPERIDONE	risperidone	TABLET;ORAL	077543-006	May 18, 2011	AB	RX	No	No
Chartwell Molecular	RISPERIDONE	risperidone	TABLET;ORAL	077543-004	May 18, 2011	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chart Medcl
• Chartwell Life Sci
• Chartwell Molecular
• Chartwell Molecules
• Chartwell Pharma
• Chartwell Rx
• Chartwell Tetra